Abstract:A supermolecular photosensitizer with excellent anticancer behavior when used for photodynamic therapy (PDT) is fabricated by the incorporation of zinc phthalocyanines (ZnPc) into the gallery of a layered double hydroxide (LDH). The composite material possesses uniform particle size (hydrodynamic diameter ∼120 nm), and the host–guest and guest–guest interactions result in a high dispersion of ZnPc in a monomeric state in the interlayer region of the LDH matrix, with high singlet oxygen production efficiency. In vitro tests performed with HepG2 cells reveal a satisfactory PDT effectiveness of the ZnPc(1.5%)/LDH composite photosensitizer: a cellular damage as high as 85.7% is achieved with a rather low dosage of ZnPc (10 μg/mL). An extraordinarily high specific efficacy is demonstrated (31.59 μg−1 (J/cm2)−1), which is over 185.5% enhancement compared with the previously reported photosensitizers under similar test conditions. Furthermore, an in vivo study of the ZnPc(1.5%)/LDH demonstrates excellent PDT performance with an ultra‐low dose (0.3 mg/kg) and a low optical fluence rate (54 J/cm2). In addition, the ZnPc/LDH photosensitizer displays high stability, good biocompatibility, and low cytotoxicity, which would guarantee its practical application. Therefore, this work provides a facile approach for design and fabrication of inorganic–organic supermolecular materials with greatly enhanced anticancer behavior.

Metal Phthalocyanine As Photosensitizer for Photodynamic Therapy (PDT)

Phthalocyanine-based coordination polymer nanoparticles for enhanced photodynamic therapy.

Studies on the synthesis and photodynamic antitumour activity of sulfonated phthalimidomethyl phthalocyanine zinc

Metalloporphyrin–indomethacin conjugates as new photosensitizers for photodynamic therapy

The Substituted Zinc(ii) Phthalocyanines Using “sulfur Bridge” As the Linkages. Synthesis, Red-Shifted Spectroscopic Properties and Structure-Inherent Targeted Photodynamic Activities

Phthalocyanine-Biomolecule Conjugated Photosensitizers For Targeted Photodynamic Therapy And Imaging

Zinc phthalocyanine-bridged periodic mesoporous organosilica nanoparticle as biodegradable photosensitizer for photodynamic therapy

Quinolin-8-yloxy-substituted zinc(II) phthalocyanines for enhanced in vitro photodynamic therapy

Improved Photodynamic Anticancer Activity and Mechanisms of a Promising Zinc(ii) Phthalocyanine-Quinoline Conjugate Photosensitizer in Vitro and in Vivo.

A Sulfur-Bridging Sulfonate-Modified Zinc(II) Phthalocyanine Nanoliposome Possessing Hybrid Type I and Type II Photoreactions with Efficient Photodynamic Anticancer Effects.

A Supermolecular Photosensitizer with Excellent Anticancer Performance in Photodynamic Therapy

A Non-Aggregated Zinc(ii) Phthalocyanine with Hexadeca Cations for Antitumor and Antibacterial Photodynamic Therapies.

A Mitochondria-Targeted Zinc(Ii) Phthalocyanine for Photodynamic Therapy

Phthalocyanine-based photosensitizer with tumor-pH-responsive properties for cancer theranostics

Probing the Interactions of Phthalocyanine-Based Photosensitizers with Model Phospholipid Bilayer by Molecular Dynamics Simulations

Photocyanine: A Novel and Effective Phthalocyanine-Based Photosensitizer for Cancer Treatment

Syntheses of Metal Phthalocyanines and Their Photoinactivations on Cancer Cells.

A Tumor-pH-Responsive Supramolecular Photosensitizer for Activatable Photodynamic Therapy with Minimal in Vivo Skin Phototoxicity.

Zinc phthalocyanine conjugated with the amino-terminal fragment of urokinase for tumor-targeting photodynamic therapy

Enhanced photodynamic efficacy of zinc phthalocyanine by conjugating to heptalysine.

In Vitro and in Vivo Evaluation of Improved EGFR Targeting Peptide-Conjugated Phthalocyanine Photosensitizers for Tumor Photodynamic Therapy